| Literature DB >> 33202732 |
Rohan Edmonds1,2, Julian Egan-Shuttler2,3, Stephen J Ives2.
Abstract
Heart rate variability (HRV) is a reputable estimate of cardiac autonomic function used across multiple athletic populations to document the cardiac autonomic responses to sport demands. However, there is a knowledge gap of HRV responses in female youth rowers. Thus, the purpose of this study was to measure HRV weekly, over a 15-week training period, covering pre-season and up to competition in youth female rowers, in order to understand the physiological response to long-term training and discern how fluctuations in HRV may relate to performance in this population. Measures of heart rate and heart rate variability were recorded before training each Friday over the monitoring period in seven athletes. Analysis of heart rate variability focused on time domain indices, the standard deviation of all normal to normal R-R wave intervals, and the root mean square of successive differences as markers of cardiac parasympathetic modulation. Training load was quantified by multiplying the rating of perceived exertion of the weeks training and training duration. A decrease was identified in cardiac parasympathetic modulation as the season progressed (Effect Size (Cohen's d) = -0.34 to -0.8, weeks 6 and 11-15), despite no significant relationship between training load and heart rate variability. Factors outside of training may further compound the reduction in heart rate variability, with further monitoring of external stressors (e.g., school) in adolescent athletes.Entities:
Keywords: adolescents; autonomic nervous system; cardiac autonomic; training load; vagal tone
Mesh:
Year: 2020 PMID: 33202732 PMCID: PMC7697086 DOI: 10.3390/ijerph17228391
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Individual participant characteristics.
| Athlete | Age (years) | Height (cm) | Weight (kg) |
|---|---|---|---|
| 1 | 15 | 175 | 74.8 |
| 2 | 17 | 178 | 65.8 |
| 3 | 17 | 175 | 69.4 |
| 4 | 18 | 168 | 71.7 |
| 5 | 16 | 178 | 64.8 |
| 6 | 17 | 183 | 79.4 |
| 7 | 16 | 160 | 47.2 |
| Mean (±sd) | 16.6 (±1.0) | 173.9 (±7.6) | 67.6 (±10.3) |
Timeline of the HR and HRV monitoring period with 2000 m ergometer trials.
| Week | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
| 2k | 2k | 2k | ||||||||||||
X—HRV recording; 2k—2000 m ergometer trial.
Mean values ± standard deviation, variance (95% CI) from baseline, Effect Size (ES), and qualitative inferences for heart rate and heart rate variability during the 15-week monitoring period.
| Week | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | |
| Mean HR | 76.4 ± 11.5 | 74.6 ± 4.3 | 77.1 ± 7.3 | 77.4 ± 7.4 | 70.2 ± 10.7 | 74.5 ± 7.4 | 74.2 ± 8.5 | 76.9 ± 10.5 | 76.1 ± 8.6 | 73.5 ± 8.4 | 76.2 ± 5.6 | 85.5 ± 6.8 | 74.0 ± 2.8 | 75.0 ± 8.0 | 73.5 ± 8.0 |
| %△ | −1.5 | 1.6 | 1.9 | −8.2 | −2.0 | −2.5 | 0.8 | 0.1 | −3.4 | 0.5 | 12.8 | −2.2 | −1.4 | −3.3 | |
| ES | −0.08 | 0.08 | 0.10 | −0.46 | −0.11 | −0.14 | 0.05 | 0.00 | −0.19 | 0.03 | 0.66 | −0.12 | −0.07 | −0.18 | |
| QI | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear | Likely | Unclear | Unclear | Unclear | |
| RMSSD | 105.3 ± 45.4 | 84.9 ± 38.2 | 83.8 ± 36.7 | 86.4 ± 37.1 | 101.7 ± 51.2 | 81.2 ± 40.9 | 96.4 ± 43.1 | 89.8 ± 26.9 | 83.6 ± 40.8 | 80.9 ± 27.4 | 56.8 ± 34.8 | 52.4 ± 29.9 | 72.6 ± 17.3 | 71.0 ± 24.3 | 78.4 ± 33.9 |
| %△ | −19.0 | −20.9 | −18.3 | −5.0 | −27.0 | −10.0 | −9.8 | −19.8 | −20.7 | −48.2 | −52.7 | −25.8 | −29.7 | −27.6 | |
| ES | −0.23 | −0.25 | −0.22 | −0.06 | −0.34 | −0.11 | −0.11 | −0.24 | −0.25 | −0.70 | −0.80 | −0.32 | −0.38 | −0.35 | |
| QI | Unclear | Unclear | Unclear | Unclear | Likely | Unclear | Unclear | Unclear | Unclear | Very Likely | Very Likely | Possibly | Likely | Likely | |
| SDNN | 100.1 ± 38.9 | 82.3 ± 21.6 | 90.1 ± 26.0 | 88.4 ± 24.7 | 98.9 ± 33.0 | 76.0 ± 31.2 | 78.9 ± 36.7 | 84.6 ± 25.6 | 75.9 ± 20.1 | 70.9 ± 27.4 | 56.7 ± 28.2 | 52.8 ± 25.1 | 69.5 ± 19.6 | 70.6 ± 22.0 | 72.2 ± 27.2 |
| %△ | −14.8 | −8.0 | −9.2 | 1.4 | −25.6 | −22.4 | −13.7 | −21.7 | −28.0 | −44.9 | −48.8 | −28.0 | −27.6 | −28.3 | |
| ES | −0.26 | −0.14 | −0.16 | 0.02 | −0.49 | −0.42 | −0.24 | −0.40 | −0.54 | −0.98 | −1.11 | −0.54 | −0.53 | −0.55 | |
| QI | Unclear | Unclear | Unclear | Unclear | Likely | Likely | Unclear | Unclear | Very Likely | Very Likely | Very Likely | Likely | Likely | Likely | |
HR—heart rate; RMSSD—root mean square of successive differences; SDNN—standard deviation of normal to normal RR intervals; % △—percent variance from baseline; CI—confidence interval; ES—effect size; QI—qualitative inference.
Figure 1Changes from baseline over the 15-week monitoring period for (A) training load, (B) mean heart rate, (C) root mean square of successive RR interval differences (RMSSD), and (D) the standard deviation of all normal to normal RR intervals (SDNN). Data are presented as means ± SD, with dashed lines representing the positive and negative percentage smallest worthwhile change (%SWC, 3%) from baseline [31]. a indicates possibly lower compared to baseline. b indicates likely lower compared to baseline. c indicates likely higher compared to baseline. d indicates very likely lower compared to baseline. e indicates very likely higher compared to baseline. * indicates likely higher compared to week 12. # indicates very likely higher compared to week 12.